The purpose of positive and negative regulation should be discussed. Concept Introduction: Enzyme: It is a protein or a molecule which can act as a catalyst for a biological reaction. Does not affect the equilibrium point of the reaction. Active site of the enzyme is the region where the reaction takes place. Enzyme’s activity can be specific which means the activity is limited to a certain substrate and a certain type of reaction and it is referred to as specificity of the enzyme. Enzyme regulation can be done by two ways: Allosteric control and feedback inhibition. Allosteric control: In this type of regulation, the binding of a molecule at one site on a protein affects the binding of another molecule at a different site. Allosteric enzymes have more than one protein chain and two kinds of binding sites. One binding site is for the substrate and other is for regulation. The advantage is that regulators need not be structurally similar to the substrate because they do not bind to the active site. Can be either positive or negative Positive regulation: It is a type of regulation in which binding a positive regulator changes an unavailable active site so that substrate can fit into the active site and the reaction occurs. Negative regulation: Binding a negative regulator changes the active site so that the enzyme can no longer bind substrate to the active site.

Question

Want to see the full answer?

Answer 1

Question

Chapter 19, Problem 19.67AP

Interpretation Introduction

Interpretation:

The purpose of positive and negative regulation should be discussed.

Concept Introduction:

Enzyme:

It is a protein or a molecule which can act as a catalyst for a biological reaction.

Does not affect the equilibrium point of the reaction.

Active site of the enzyme is the region where the reaction takes place.

Enzyme’s activity can be specific which means the activity is limited to a certain substrate and a certain type of reaction and it is referred to as specificity of the enzyme.

Enzyme regulation can be done by two ways: Allosteric control and feedback inhibition.

Allosteric control:

In this type of regulation, the binding of a molecule at one site on a protein affects the binding of another molecule at a different site.

Allosteric enzymes have more than one protein chain and two kinds of binding sites.

One binding site is for the substrate and other is for regulation.

The advantage is that regulators need not be structurally similar to the substrate because they do not bind to the active site.

Can be either positive or negative

Positive regulation: It is a type of regulation in which binding a positive regulator changes an unavailable active site so that substrate can fit into the active site and the reaction occurs.

Negative regulation: Binding a negative regulator changes the active site so that the enzyme can no longer bind substrate to the active site.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

Do schwann cells produce or act as myelin in the peripheral nervous system? I know that they encase and wrap around axons, but where does the myelin come into play?

The enzyme lactate dehydrogenase (LDH) catalyzes the conversion of pyruvate to lactatein skeletal muscle cells using NAD/NADH during anaerobic “balanced” fermentation.Answer the following questions about this reaction. (a) Write out the two reductive half reactions and indicate the E ̊' for each half reaction. Write out the full balanced reaction for the pyruvate to lactate rxn and indicate the ∆E ̊' for the reaction. (b) What is the free energy change under standard state conditions for thisreaction? Which direction is spontaneous?(c) Assume that in skeletal muscle cells the ratio of [NAD+] to [NADH] is 100, and that the[pyruvate] = 0.40 mM and [lactate] = 4.0 mM. What is the free energy change (∆G')for the conversion of pyruvate to lactate? Indicate the direction in which the reactionis spontaneous under these cellular conditions.

Why did the authors worry about the temperature-dependent solubility of the carriers in thebilayer? How did the authors determine whether the effect of freezing the lipid bilayer wasto decrease the solubility of the carriers (nonactin and valinomycin) or whether the effectwas to impair their ability to diffuse through the membrane (decrease their mobility)?